Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers

Clinical Cancer Research

Volumn 9, Issue 5, 2003, Pages 1710-1720

  Dong, Ying ^a   Kaushal, Aneel ^a   Brattsand, Maria ^b   Nicklin, Jim ^c   Clements, Judith A ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b UMEÅ UNIVERSITY   (Sweden)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA TUBULIN; PROTEIN; PROTEIN HK5; PROTEIN HK7; TUMOR MARKER; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADENOMA; ARTICLE; CANCER CELL CULTURE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; EPIDERMIS; EPITHELIAL OVARIAN CANCER; EXPRESSED SEQUENCE TAG; FEMALE; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KALLIKREIN GENE; KLK5 GENE; KLK7 GENE; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; OVARIAN ADENOMA; OVARY CANCER; OVARY CARCINOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; RNA TRANSCRIPTION; SOUTHERN BLOTTING; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; 5' UNTRANSLATED REGIONS; ADENOCARCINOMA, CLEAR CELL; ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; CARCINOMA, ENDOMETRIOID; COHORT STUDIES; CYSTADENOCARCINOMA, SEROUS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KALLIKREINS; MOLECULAR SEQUENCE DATA; OVARIAN NEOPLASMS; OVARY; PROGNOSIS; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; SERINE ENDOPEPTIDASES; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; VARIATION (GENETICS);

EID: 0038327753     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Risch, H. A. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J. Natl. Cancer. Inst. (Bethesda), 90: 1774-1786, 1998.
2. Landis, S. H., Murray, T., Bolden, S., and Wingo, P. A. Cancer statistics, 1998. CA Cancer J. Clin., 48: 6-29, 1998.
3. Harvey, T. J., Hooper, J. D., Myers, S. A., Stephenson, S. A., Ashworth, L. K., and Clements, J. A. Tissue-specific expression patterns and fine mapping of the human kallikrein (KLK) locus on proximal 19q13.4. J. Biol. Chem., 275: 37397-37406, 2000.
4. Yousef, G. M., Chang, A., Scorilas, A., and Diamandis, E. P. Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4. Biochem. Biophys. Res. Commun., 276: 125-133, 2000.
5. Dong, Y., Kaushal, A., Bui, L., Chu, S., Fuller, P. J., Nicklin, J., Samaratunga, H., and Clements, J. A. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas. Clin. Cancer Res., 7: 2363-2371, 2001.
6. Obiezu, C. V., Scorilas, A., Katsaros, D., Massobrio, M., Yousef, G. M., Fracchioli, S., Rigault De La Longrais, I. A., Arisio, R., and Diamandis, E. P. Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients. Clin. Cancer Res., 7: 2380-2386, 2001.
7. Anisowicz, A., Sotiropoulou, G., Stenman, G., Mok, S. C., and Sager, R. A novel protease homolog differentially expressed in breast and ovarian cancer. Mol. Med., 2: 624-636, 1996.
8. Tanimoto, H., Underwood, L. J., Shigemasa, K., Parmley, T. H., and O'Brien. T. J. Increased expression of protease M in ovarian tumors. Tumour Biol., 22: 11-18, 2001.
9. Diamandis, E. P., Yousef, G. M., Soosaipillai, A. R., and Bunting, P. Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma. Clin. Biochem., 33: 579-583, 2000.
10. Underwood, L. J., Tanimoto, H., Wang, Y., Shigemasa, K., Parmley, T. H., and O'Brien, T. J. Cloning of tumor-associated differentially expressed gene-14, a novel serine protease overexpressed by ovarian carcinoma. Cancer Res., 59: 4435-4439, 1999.
11. Magklara, A., Scorilas, A., Katsaros, D., Massobrio, M., Yousef, G. M., Fracchioli, S., Danese, S., and Diamandis, E. P. The human KLK8 (neuropsin/ovasin) gene: identification of two novel splice variants and its prognostic value in ovarian cancer. Clin. Cancer Res., 7: 806-811, 2001.
12. Yousef, G. M., Kyriakopoulou, L. G., Scorilas, A., Fracchioli, S., Ghiringhello, B., Zarghooni, M., Chang, A., Diamandis, M., Giardina, G., Hartwick, W. J., Richiardi, G., Massobrio, M., Diamandis, E. P., and Katsaros, D. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker. Cancer Res., 61: 7811-7818, 2001.
13. Luo, L. Y., Katsaros, D., Scorilas, A., Fracchioli, S., Piccinno, R., Rigault de la Longrais, I. A., Howarth, D. J., and Diamandis, E. P. Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma. Clin. Cancer Res., 7: 2372-2379, 2001.
14. Diamandis, E. P., Okui, A., Mitsui, S., Luo, L. Y., Soosaipillai, A., Grass, L., Nakamura, T., Howarth, D. J., and Yamaguchi, N. Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma. Cancer Res., 62: 295-300, 2002.
15. Brattsand, M., and Egelrud, T. Purification, molecular cloning, and expression of a human stratum comeum trypsin-like serine protease with possible function in desquamation. J. Biol. Chem., 274: 30033-30040, 1999.
16. Egelrud, T. Purification and preliminary characterization of stratum comeum chymotryptic enzyme: a proteinase that may be involved in desquamation. J. Investig. Dermatol., 101: 200-204, 1993.
17. Hansson, L., Stromqvist, M., Backman, A., Wallbrandt, P., Carlstein, A., and Egelrud, T. Cloning, expression, and characterization of stratum corneum chymotryptic enzyme. A skin-specific human serine proteinase. J. Biol. Chem., 269: 19420-19426, 1994.
18. Ekholm, I. E., Brattsand, M., and Egelrud, T. Stratum corneum tryptic enzyme in normal epidermis: a missing link in the desquamation process?. J. Investig. Dermatol., 114: 56-63, 2000.
19. Gan, L., Lee, I., Smith, R., Argonza-Barrett, R., Lei, H., McCuaig, J., Moss, P., Paeper, B., and Wang, K. Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region. Gene (Amst.), 257: 119-130, 2000.
20. Kim, H., Scorilas, A., Katsaros, D., Yousef, G. M., Massobrio, M., Fracchioli, S., Piccinno, R., Gordini, G., and Diamandis, E. P. Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer. Br. J. Cancer, 84: 643-650, 2001.
21. Tanimoto, H., Underwood, L. J., Shigemasa, K., Yan Yan, M. S., Clarke, J., Parmley, T. H., and O'Brien. T. J. The stratum comeum chymotryptic enzyme that mediates shedding and desquamation of skin cells is highly overexpressed in ovarian tumor cells. Cancer (Phila.), 86: 2074-2082, 1999.
22. Godwin, A. K., Testa, J. R., Handel, L. M., Liu, Z., Vanderveer, L. A., Tracey, P. A., and Hamilton, T. C. Spontaneous transformation of rat ovarian surface epithelial cells: association with cytogenetic changes and implications of repeated ovulation in the etiology of ovarian cancer. J. Natl. Cancer Inst. (Bethesda), 84: 592-601, 1992.
23. Sondell, B., Dyberg, P., Anneroth, G. K., Ostman, P. O., and Egelrud, T. Association between expression of stratum corneum chymotryptic enzyme and pathological keratinization in human oral mucosa. Acta Dermato-Venereol., 76: 177-181, 1996.
24. Yousef, G. M., and Diamandis, E. P. The new kallikrein-like gene, KLK-L2. Molecular characterization, mapping, tissue expression, and hormonal regulation. J. Biol. Chem., 274: 37511-37516, 1999.
25. Yousef, G. M., Scorilas, A., Magklara, A., Soosaipillai, A., and Diamandis, E. P. The KLK7 (PRSS6) gene, encoding for the stratum corneum chymotryptic enzyme, is a new member of the human kallikrein gene family: genomic characterization, mapping, tissue expression and hormonal regulation. Gene (Amst.), 254: 119-128, 2000.
26. Noel, A., Albert, V., Bajou, K., Bisson, C., Devy, L., Frankenne, F., Maquoi, E., Masson, V., Sounni, N. E., and Foidart, J. M. New functions of stromal proteases and their inhibitors in tumor progression. Surg. Oncol. Clin. N. Am., 10: 417-432, x-xi, 2001.
27. Rittenhouse, H. G., Finlay, J. A., Mikolajczyk, S. D., and Partin, A. W. Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate. Crit. Rev. Clin. Lab. Sci., 35: 275-368, 1998.
28. Egelrud, T., Regnier, M., Sondell, B., Shroot, B., and Schmidt, R. Expression of stratum corneum chymotryptic enzyme in reconstructed human epidermis and its suppression by retinoic acid. Acta Dermato-Venereol., 73: 181-184, 1993.
29. Kato, K., Kishi, T., Kamachi, T., Akisada, M., Oka, T., Midorikawa, R., Takio, K., Dohmae, N., Bird, P. I., Sun, J., Scott, F., Miyake, Y., Yamamoto, K., Machida, A., Tanaka, T., Matsumoto, K., Shibata, M., and Shiosaka, S. Serine proteinase inhibitor 3 and murinoglobulin I are potent inhibitors of neuropsin in adult mouse brain. J. Biol. Chem., 276: 14562-14571, 2001.
30. Franzke, C. W., Baici, A., Barrels, J., Christophers, E., and Wiedow. O. Antileukoprotease inhibits stratum corneum chymotryptic enzyme. Evidence for a regulative function in desquamation. J. Biol. Chem., 271: 21886-21890, 1996.
31. Shigemasa, K., Tanimoto, H., Underwood, L. J., Parmley, T. H., Arihiro, K., Ohama, K., and O'Brien, T. J. Expression of the protease inhibitor antileukoprotease and the serine protease stratum corneum chymotryptic enzyme (SCCE) is coordinated in ovarian tumors. Int. J. Gynecol. Cancer, 11: 454-461, 2001.
32. Kos, M., O'Brien, S., Flouriot, G., and Gannon, F. Tissue-specific expression of multiple mRNA variants of the mouse estrogen receptor α gene. FEBS Lett., 477: 15-20, 2000.
33. Serov, S. F., and Scully, R. E. Histological Typing of Ovarian Tumours. Geneva: WHO, 1973.